Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
Anesa Mulabecirovic, Portfolio Manager at DNB Asset Management, shared a post on LinkedIn:
“The most common inherited bleeding disorder takes an average of sixteen years to diagnose in women.
Not because it is rare. It is not. The delay is about where the bleeding gets recorded.
A girl can bleed heavily from her first period, and the note that follows reads ‘heavy periods,’ not ‘possible clotting defect.’
She is routed to gynecology, not hematology. The symptom is counted. The disorder behind it is not.
Global registries identify von Willebrand disease in roughly 26 people per million.
Clinically significant disease runs closer to 1 in 1000.
Either way the treated population is a fraction of the real one, and the gap is a recording problem, not a biology one.
A market can only price what has a label.
The clinic meets the patient before the label exists, and that gap is larger than the numbers suggest.”
Stay updated with Hemostasis Today.
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines
-
Nov 15, 2026, 20:50Asmaa Beltagy: Efficacy and Safety of Eltrombopag in SLE-Associated Immune Thrombocytopenia
-
Nov 15, 2026, 16:29Jean-Jacques Kiladjian: 20 Years of Interferon-Alpha Research in Myeloproliferative Neoplasms
-
Nov 15, 2026, 16:21Sukanto Paul: Why Platelet Transfusion Is Generally Avoided in TTP
-
Nov 15, 2026, 16:14Ahmad G. Alzahrani: Major Bleeding and Anticoagulant Reversal
-
Nov 15, 2026, 16:05Sabine Eichinger: Is Recurrence Risk After Provoked VTE Really Low?